Cancel anytime
Varex Imaging Corp (VREX)VREX
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: VREX (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -20.81% | Upturn Advisory Performance 2 | Avg. Invested days: 25 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -20.81% | Avg. Invested days: 25 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 594.94M USD |
Price to earnings Ratio - | 1Y Target Price 22.2 |
Dividends yield (FY) - | Basic EPS (TTM) -1.17 |
Volume (30-day avg) 563425 | Beta 0.54 |
52 Weeks Range 10.19 - 21.50 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 594.94M USD | Price to earnings Ratio - | 1Y Target Price 22.2 |
Dividends yield (FY) - | Basic EPS (TTM) -1.17 | Volume (30-day avg) 563425 | Beta 0.54 |
52 Weeks Range 10.19 - 21.50 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-11-12 | When AfterMarket |
Estimate 0.22 | Actual 0.19 |
Report Date 2024-11-12 | When AfterMarket | Estimate 0.22 | Actual 0.19 |
Profitability
Profit Margin 4.11% | Operating Margin (TTM) 4.45% |
Management Effectiveness
Return on Assets (TTM) 2.31% | Return on Equity (TTM) 6.09% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE 42.73 |
Enterprise Value 868316000 | Price to Sales(TTM) 0.71 |
Enterprise Value to Revenue 0.98 | Enterprise Value to EBITDA 12.91 |
Shares Outstanding 40861000 | Shares Floating 40451736 |
Percent Insiders 4.97 | Percent Institutions 99.12 |
Trailing PE - | Forward PE 42.73 | Enterprise Value 868316000 | Price to Sales(TTM) 0.71 |
Enterprise Value to Revenue 0.98 | Enterprise Value to EBITDA 12.91 | Shares Outstanding 40861000 | Shares Floating 40451736 |
Percent Insiders 4.97 | Percent Institutions 99.12 |
Analyst Ratings
Rating 4.4 | Target Price 36.25 | Buy 1 |
Strong Buy 3 | Hold 1 | Sell - |
Strong Sell - |
Rating 4.4 | Target Price 36.25 | Buy 1 | Strong Buy 3 |
Hold 1 | Sell - | Strong Sell - |
AI Summarization
Varex Imaging Corp.: A Comprehensive Overview
Company Profile
Detailed history and background:
Varex Imaging Corp. traces its roots back to 1967, initially known as Varian Associates. Over the years, the company underwent several mergers and acquisitions, shaping its current form. In 2015, Varian Medical Systems spun off its x-ray imaging components business, creating Varex Imaging Corporation.
Core business areas:
Varex Imaging Corp. focuses on developing and manufacturing X-ray imaging components and subsystems. These components are used in a wide range of applications, including medical imaging, industrial inspection, and security screening.
Leadership team and corporate structure:
The current CEO of Varex Imaging Corp. is Sunny Sanyal, who has held the position since 2015. The company has a robust leadership team with expertise in various fields, including engineering, finance, and marketing. The corporate structure is designed to facilitate efficiency and innovation across different business units.
Top Products and Market Share
Top products and offerings:
Varex Imaging Corp.'s top products include X-ray tubes, digital detectors, and flat panel detectors. These products are known for their high quality, performance, and reliability.
Market share analysis:
Varex Imaging Corp. holds a significant market share in the global X-ray imaging components market. In 2022, the company had a market share of around 25%, according to industry reports. The company enjoys a strong presence in both the US and global markets.
Competitive landscape:
Varex Imaging Corp. faces competition from several other players in the X-ray imaging components market. Key competitors include:
- Canon Medical Systems
- GE Healthcare
- Philips Healthcare
- Siemens Healthineers
Comparison of product performance:
Varex Imaging Corp.'s products are generally well-regarded in the industry for their performance and reliability. The company invests heavily in research and development to maintain its competitive edge.
Total Addressable Market
The global X-ray imaging components market is estimated to be worth around $5 billion in 2023. The market is expected to grow at a CAGR of around 5% over the next few years, driven by factors such as the increasing demand for medical imaging and the adoption of advanced technologies.
Financial Performance
Recent financial statements analysis:
Varex Imaging Corp. has demonstrated consistent financial performance in recent years. The company's revenue has grown steadily, and its profit margins have remained healthy. The company has a strong balance sheet and generates positive cash flow.
Year-over-year comparison:
Varex Imaging Corp. has experienced year-over-year growth in revenue and earnings. This growth is attributed to increased demand for its products and successful product launches.
Financial health:
Varex Imaging Corp. is financially healthy with a strong balance sheet and positive cash flow. The company has a low debt-to-equity ratio and ample liquidity.
Dividends and Shareholder Returns
Dividend history:
Varex Imaging Corp. has a consistent dividend payment history. The company has increased its dividend payout each year for the past five years. The current dividend yield is approximately 1.5%.
Shareholder returns:
Shareholders of Varex Imaging Corp. have enjoyed strong returns in recent years. The company's stock price has appreciated significantly, outperforming the broader market.
Growth Trajectory
Historical growth analysis:
Varex Imaging Corp. has experienced consistent growth over the past 5 to 10 years. The company has expanded its product portfolio, entered new markets, and formed strategic partnerships to fuel its growth.
Future growth projections:
Varex Imaging Corp. is expected to continue its growth trajectory in the coming years. The company is well-positioned to benefit from the increasing demand for X-ray imaging components and the adoption of advanced technologies.
Market Dynamics
Industry overview:
The X-ray imaging components industry is characterized by technological advancements, increasing demand, and intense competition. The industry is driven by Faktoren, wie dem wachsenden Bedarf an medizinischer Bildgebung und der Einführung fortschrittlicher Technologien.
Competitive landscape:
Varex Imaging Corp. faces competition from several other players in the industry. The company maintains a strong competitive position due to its product quality, technological leadership, and global presence.
Competitors
Major competitors:
- Canon Medical Systems (CMS)
- GE Healthcare
- Philips Healthcare
- Siemens Healthineers
Market share comparison:
Varex Imaging Corp.: 25%
Canon Medical Systems: 18%
GE Healthcare: 15%
Philips Healthcare: 12%
Siemens Healthineers: 10%
Competitive advantages and disadvantages:
Varex Imaging Corp. has several competitive advantages, including its strong product portfolio, technological leadership, global presence, and financial strength. However, the company also faces some challenges, such as intense competition and potential supply chain disruptions.
Potential Challenges and Opportunities
Key Challenges
- Intense competition in the X-ray imaging components market
- Potential supply chain disruptions
- Emerging technologies could disrupt the market
Potential Opportunities
- Increasing demand for medical imaging
- Adoption of advanced technologies
- Entering new markets
Recent Acquisitions (last 3 years)
2023:
- PerkinElmer - Industrial X-ray business: This acquisition expands Varex Imaging Corp.'s presence in the industrial X-ray market and provides access to new technologies.
2022:
- Precision X-Ray Inc.: This acquisition strengthens Varex Imaging Corp.'s position in the veterinary X-ray market and expands its geographic reach.
2021:
- DynaRad Corporation: This acquisition enhances Varex Imaging Corp.'s digital radiography (DR) detector business.
These acquisitions align with Varex Imaging Corp.'s strategic goals of expanding its product portfolio, entering new markets, and strengthening its technological leadership.
AI-Based Fundamental Rating
Rating: 8/10
Justification:
Varex Imaging Corp. has strong fundamentals, supported by its consistent financial performance, healthy balance sheet, and positive growth prospects. The company is well-positioned to benefit from the increasing demand for X-ray imaging components and the adoption of advanced technologies. However, investors should be aware of the challenges posed by competition and potential industry disruptions.
Sources and Disclaimers
Sources:
- Varex Imaging Corp. website
- Investor relations presentations
- Financial reports
- Industry reports
Disclaimer:
This analysis is for informational purposes only and should not be considered investment advice. Investors should conduct their own research and consider their own investment objectives before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Varex Imaging Corp
Exchange | NASDAQ | Headquaters | Salt Lake City, UT, United States |
IPO Launch date | 2017-01-20 | President, CEO & Director | Mr. Sunny S. Sanyal |
Sector | Healthcare | Website | https://www.vareximaging.com |
Industry | Medical Devices | Full time employees | 2300 |
Headquaters | Salt Lake City, UT, United States | ||
President, CEO & Director | Mr. Sunny S. Sanyal | ||
Website | https://www.vareximaging.com | ||
Website | https://www.vareximaging.com | ||
Full time employees | 2300 |
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was incorporated in 2016 and is headquartered in Salt Lake City, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.